Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Marie

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Neuro-Oncology|June 12, 2008
Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomasAhmed Idbaih, Emmanuelle Crinière, Yannick Marie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2010
Genetic risk profiles identify different molecular etiologies for gliomaMatthias Simon, Fay J Hosking, Yannick Marie, et al.
Cells|May 14, 2022
miR-324-5p and miR-30c-2-3p Alter Renal Mineralocorticoid Receptor Signaling under HypertonicityThi An Vu, Ingrid Lema, Imene Hani, et al.
Journal of Neuro-Oncology|March 5, 2014
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomasEmeline Gillet, Agusti Alentorn, Brahima Doukouré, et al.
Molecular Cancer|September 9, 2010
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patientsFrançois Ducray, Aurélien de Reyniès, Olivier Chinot, et al.
Neuro-Oncology|November 11, 2020
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratificationGiulia Berzero, Anna Luisa Di Stefano, Susanna Ronchi, et al.
Biomed Research International|August 9, 2017
<i>EGFR</i> Amplification and <i>IDH</i> Mutations in Glioblastoma Patients of the Northeast of MoroccoNadia Senhaji, Sara Louati, Laila Chbani, et al.
Neuro-Oncology|December 14, 2019
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomasRomain Appay, Caroline Dehais, Claude-Alain Maurage, et al.
Frontiers in Neurology|August 15, 2020
Exome Sequencing Reveals Signal Transduction Genes Involved in Impulse Control Disorders in Parkinson's DiseaseSabine Prud'hon, Samir Bekadar, Agnès Rastetter, et al.
The Oncologist|July 27, 2019
Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway AlterationsWilliam Boisseau, Philipp Euskirchen, Karima Mokhtari, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Neuro-Oncology|June 12, 2008
Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomasAhmed Idbaih, Emmanuelle Crinière, Yannick Marie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2010
Genetic risk profiles identify different molecular etiologies for gliomaMatthias Simon, Fay J Hosking, Yannick Marie, et al.
Cells|May 14, 2022
miR-324-5p and miR-30c-2-3p Alter Renal Mineralocorticoid Receptor Signaling under HypertonicityThi An Vu, Ingrid Lema, Imene Hani, et al.
Journal of Neuro-Oncology|March 5, 2014
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomasEmeline Gillet, Agusti Alentorn, Brahima Doukouré, et al.
Molecular Cancer|September 9, 2010
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patientsFrançois Ducray, Aurélien de Reyniès, Olivier Chinot, et al.
Neuro-Oncology|November 11, 2020
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratificationGiulia Berzero, Anna Luisa Di Stefano, Susanna Ronchi, et al.
Biomed Research International|August 9, 2017
<i>EGFR</i> Amplification and <i>IDH</i> Mutations in Glioblastoma Patients of the Northeast of MoroccoNadia Senhaji, Sara Louati, Laila Chbani, et al.
Neuro-Oncology|December 14, 2019
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomasRomain Appay, Caroline Dehais, Claude-Alain Maurage, et al.
Frontiers in Neurology|August 15, 2020
Exome Sequencing Reveals Signal Transduction Genes Involved in Impulse Control Disorders in Parkinson's DiseaseSabine Prud'hon, Samir Bekadar, Agnès Rastetter, et al.
The Oncologist|July 27, 2019
Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway AlterationsWilliam Boisseau, Philipp Euskirchen, Karima Mokhtari, et al.
Pageof 10